| 10. Positron Emission Tomography in the Presurgical Evaluation of Patients with Resectable Liver Metastases from Colorectal Carcinoma Detected by Computed Tomography with Arterial Portography. A Cost Analysis. | |
| | |
MedLine Citation:
|
PMID: 11150767 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Purpose: To assess the cost of implementing 18F-Fluorodeoxyglucose (18FDG) PET scan in the presurgical evaluation of patients with hepatic metastases from colorectal cancer (CRC) detected by Computed Tomography with arterial portography (CTAP).Methods: We performed a cost analysis of two diagnostic pathways based on a population of CRC patients with metastatic disease limited to the liver by (CTAP). The payers' perspective was utilized. The algorithms compared 18FDG-PET with Computed Tomography (CT) versus CT alone. Patients found to have extrahepatic disease by 18FDG-PET or CT were assigned to palliative care. Patients found to be negative for extrahepatic extension were assumed to be surgically resectable. The prevalence of extrahepatic disease, true and false positives and negatives for CT and 18FDG-PET were extracted from published reports (Medline, 1991 to 1999). Three possible outcomes for surgery were considered: uncomplicated, complicated, and death. Surgical complications considered were: urinary tract infection, wound sepsis, intra-abdominal abscess, septicemia, pneumonia, deep venous thrombosis, pulmonary embolism, anemia requiring transfusion, and myocardial infarction. Complication rates, costs for CT, CTAP, 18FDG-PET, surgery and post-surgical complications were obtained from HCFA published data (1997-2000). Palliative care costs were assumed to be identical in both branches.Results: Average expected cost per patient with 18FDG-PET was $16,921, compared to $21,693 for a patient without PET scan. This represents net savings of $4,772 if PET is included in the diagnostic work up.Conclusion: Integration of 18FDG-PET in the presurgical evaluation of patients with liver metastases from CRC by CTP would substantially reduce overall costs. |
| | |
Authors:
|
Zubeldia; Bednarczyk; Nabi |
Related Documents
:
|
2354407 - Staging of renal carcinoma using magnetic resonance imaging at 1.5 tesla. 17513817 - Imaging in local staging of gastric cancer: a systematic review. 18243447 - Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown prima... 12397467 - 123i-n-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous m... 15894407 - White matter mapping in alzheimer's disease: a neuropathological study. 18026907 - Extensive lipomatosis of the small bowel and mesentery: ct and mri findings. |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Clinical positron imaging : official journal of the Institute for Clinical P.E.T Volume: 3 ISSN: - ISO Abbreviation: Clin. Positron Imaging Publication Date: 2000 Jul |
Date Detail:
|
Created Date: 2001-01-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9810966 Medline TA: Clin Positron Imaging Country: - |
Other Details:
|
Languages: ENG Pagination: 164 Citation Subset: - |
Affiliation:
|
Department of Nuclear Medicine, State University of New York at Buffalo, Buffalo, NY, USA |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: 9. Assessment of Intrathoracic Metastatic Lung Cancer using FDG-PET and CT of the Thorax.
Next Document: 11. Evaluation of Patients with Known Mesothelioma with 18F-Fluorodeoxyglucose and PET. Comparison w...